Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
28,392
Total Claims
$3.7M
Drug Cost
2,558
Beneficiaries
$1,464
Cost/Patient
Risk Score Breakdown 6/100
Score components are additive. Read full methodology
Peer Comparison vs. 18,720 Cardiology providers
-4%
Cost per patient vs peers
$1,464 vs $1,524 avg
+17%
Brand preference vs peers
16.0% vs 13.7% avg
Opioid Prescribing
0.1%
Opioid Rate
21
Opioid Claims
$760
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 4,526 claims · $3.1M
Generic: 23,753 claims · $671K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 866 | $744K |
| Rivaroxaban | 761 | $666K |
| Sacubitril/Valsartan | 409 | $431K |
| Empagliflozin | 155 | $138K |
| Evolocumab | 154 | $98K |
| Semaglutide | 83 | $95K |
| Ambrisentan | 25 | $85K |
| Ticagrelor | 124 | $81K |
| Icosapent Ethyl | 167 | $72K |
| Dulaglutide | 45 | $70K |
| Dapagliflozin Propanediol | 90 | $67K |
| Sitagliptin Phosphate | 64 | $54K |
| Alirocumab | 57 | $49K |
| Ranolazine | 416 | $48K |
| Insulin Aspart | 43 | $33K |
Prescribing Profile
Patient Profile
75
Avg Age
51%
Female
1.62
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data